Lynn Honderd
Chief Executive Officer

Lynn is co-founder and CEO of Mary’s Medicinals. She also leads Mary’s Foundation for Caring, a 501(c)(3) foundation dedicated to patient education and outreach.

Over the course of more than fifteen years experience in capital markets, Lynn was instrumental in the marketing strategy and successful IPO execution of many companies across diverse industry sectors. She has served in a variety of senior positions with organizations including Bank of America and UBS Paine Webber.

Lynn’s expertise in financial services and business development has proven invaluable in the quickly evolving cannabis industry. With her strong acumen for managing complex business operations, Lynn has conquered the labyrinth of local, state and national cannabis regulatory requirements — an integral part of Mary’s fast success.

Evaluating new business opportunities and partnerships from all angles, Lynn has helped to position Mary’s Medicinals as the leading producer of pharmaceutical-grade cannabis products in multiple states. Her dedication to quality, accuracy and innovation enables Mary’s to bring to market unique products that isolate the benefits of cannabis and other vital plant extracts for optimum patient care.

Lynn holds a BS in Finance from Pepperdine University and BS in International Business from University of San Francisco.

Jeremy Riggle, Ph.D.
Chief Scientist

Dr. Jeremy Riggle received his Ph.D. in Analytical Chemistry from the University of Idaho in Moscow, ID, after being awarded an M.S. in Environmental Chemistry also from the University of Idaho and a B.S. in Biology from Eastern Oregon University in La Grande, OR. He then worked in the Division of Atmospheric Sciences at Desert Research Institute in Reno, NV, where he focused on the characterization and source apportionment of carbonaceous particulate matter.

Following his time at DRI, he worked in the Food Safety and Environmental Stewardship laboratory at Oregon State University in Corvallis, OR, a toxicology lab where he concentrated on the environmental fate of Polynuclear Aromatic Hydrocarbons. More recently, Dr. Riggle was an associate professor of chemistry in the Department of Chemistry & Biochemistry at his alma mater, Eastern Oregon University.

Shortly after arriving at EOU, Dr. Riggle co-founded EOA, a cannabis research and quality control laboratory and, prior to joining Mary’s, spent the past several years focusing on the analytics of cannabis, its associated compounds, and various cannabinoid formulations.

Robin Swinney
Chief Financial Officer

Robin is Chief Finance Officer for Mary’s Medicinals and manages all accounting and finance for Mary’s Medicinals and its affiliates.  Since 2005, Robin has owned an accounting and CFO firm with offices in Utah and Colorado.  In 2010 her firm began focusing on the cannabis industry in Colorado and she has an in-depth understanding of the complex regulatory and financial reporting our industry requires.  Robin also has experience in public accounting working as an auditor with Deloitte and Touche.